News and updates

A new international meta-analysis, led by researchers at the University of NSW and published in the journal Biological Psychiatry, has reported an association between cannabis use and earlier onset of psychosis in adults.

Join those who took part in CCA's recent Canberra delegation for a firsthand briefing

Cannabis Council Australia MyHealthRecord consultation response

Cannabis Council Australia welcomes the opportunity to provide feedback on the remaking of the Narcotic Drugs Regulation 2016 and the Narcotic Drugs (Licence Charges) Regulation 2016.

CCA welcomes the opportunity to provide feedback on the proposed endorsement for scheduled medicines for pharmacists

Join us for an informative webinar to explore the practical implications of the proposed changes to the NSW driving laws for people taking medical cannabis.

Cannabis Council Australia (CCA) has welcomed legislation introduced by the Minns Labor Government that would finally allow legally prescribed medicinal cannabis patients to drive in NSW.

Cannabis Council Australia (CCA) is intensifying its push for structural reform of Australia's medicinal cannabis sector with the launch of its Reform Working Group. This builds on a CCA consultation currently underway on proposed revisions to product labelling requirements under TGO 93

A spokesperson for the Cannabis Council of Australia, which represents medicinal cannabis producers, prescribers and pharmacists, said the decline was a sign of the industry maturing after rapid growth. ‘‘Moderation of overall volumes is representative of the sector's focus on clinical governance, patient suitability, and continuity of care,'' they said.

Please find attached correspondence from Cannabis Council Australia in response the TGA communique of 19 March seeking feedback from the medicinal cannabis sector regarding the draft Standards checklist for medicinal cannabis vaping devices.

The launch of the Australian Pain Alliance, held at Parliament House on March 30 2026 marks a pivotal moment for pain advocacy in Australia. This landmark event, proudly supported by Cannabis Council Australia, brought together people with lived experience, clinicians, researchers, and policymakers to formally unite under a shared national voice — focused on improving pain policy, care, and outcomes across the country. Led by Chronic Pain Australia, the Alliance represents millions of Australians affected by pain and the professionals who support them. ‍

Cannabis Council Australia is holding a briefing session for sector stakeholders on potential rescheduling activity on medicinal cannabis, how scheduling is managed and what it means for the sector.

The peak body for medicinal cannabis prescribers says the review's findings do not indicate a death knell for the industry.

Cannabis Council Australia welcomes a new article published in Lancet Psychiatry this week, noting it adds to the ongoing discussion about the clinical evidence base for medicinal cannabis.

Prepared by the UK Association of Police Controlled Drug Liaison Officers (APCDLO)

Cannabis Council Australia is seeking the Australian Treasury’s consideration of funding measures in the 2026–27 Budget that will strengthen safety, quality and system integrity for medicinal cannabis products accessed by patients across Australia.

The Australian Therapeutic Goods Administration undertook a consultation on the regulation of medicinal cannabis which closed on 7 October 2025.

Cannabis Council Australia's position on current arrangements for workplace drug testing in the context of legally prescribed medicinal cannabis.

This paper lays out the current legal status of medicinal cannabis and driving in Australia

A new industry campaign, Road to Reform, has recently launched, supporting state amendments to driving laws after a survey of thousands of patients found more than 99% back the call for change.

A recent survey of more that 6,000 medical cannabis patients showed that 61% were reluctant to discuss their medical treatment, with many citing concerns around perceptions of cannabis in the community.

Bill introduced on Tuesday will allow medicinal cannabis users to take part in closed-circuit trial

Recent submissions to the industry regulator outline how requirements to avoid the term ‘medical cannabis’ has caused uncertainty for patients, and not being able to speak in plain English causes real harm and confusion around available treatment options.